RAMM Pharma Corp. (CSE:RAMM)
0.0200
0.00 (0.00%)
Feb 4, 2025, 11:00 AM EST
RAMM Pharma Balance Sheet
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2018 - 2019 |
Cash & Equivalents | 0.48 | 0.81 | 5.12 | 9.77 | 17.16 | 28.01 | Upgrade
|
Cash & Short-Term Investments | 0.48 | 0.81 | 5.12 | 9.77 | 17.16 | 28.01 | Upgrade
|
Cash Growth | -87.66% | -84.09% | -47.65% | -43.03% | -38.74% | -20.82% | Upgrade
|
Accounts Receivable | 1.96 | 0.78 | 0.62 | 0.92 | 1.17 | 1.1 | Upgrade
|
Other Receivables | 0 | 0.86 | 1.26 | 1.83 | 2.78 | 0.25 | Upgrade
|
Receivables | 1.96 | 1.64 | 1.88 | 2.74 | 3.95 | 1.35 | Upgrade
|
Inventory | 2.02 | 2.54 | 3.14 | 4.02 | 3.05 | 1.79 | Upgrade
|
Prepaid Expenses | - | 0.26 | 0.22 | 0.08 | 0.06 | - | Upgrade
|
Other Current Assets | - | 0.1 | 0.24 | 0.03 | 0.06 | 0.07 | Upgrade
|
Total Current Assets | 4.46 | 5.36 | 10.59 | 16.65 | 24.28 | 31.22 | Upgrade
|
Property, Plant & Equipment | 10.98 | 11.2 | 19.05 | 19.71 | 19.34 | 2.29 | Upgrade
|
Goodwill | - | - | - | - | 12.85 | - | Upgrade
|
Other Intangible Assets | 0.11 | 0.19 | 0.49 | 0.8 | 1.47 | 1.46 | Upgrade
|
Other Long-Term Assets | - | - | 2.17 | 2.08 | 1.86 | 2.2 | Upgrade
|
Total Assets | 15.55 | 16.75 | 32.3 | 39.24 | 59.8 | 37.17 | Upgrade
|
Accounts Payable | 2.92 | 0.64 | 1.21 | 1.11 | 1.93 | 0.5 | Upgrade
|
Accrued Expenses | - | 0.36 | 0.33 | 0.56 | 0.48 | 0.45 | Upgrade
|
Current Portion of Leases | 0.12 | 0.1 | 0.23 | 0.23 | 0.03 | 0.08 | Upgrade
|
Current Income Taxes Payable | - | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
Other Current Liabilities | - | 1.92 | 0.87 | 1.3 | 0.87 | 0.28 | Upgrade
|
Total Current Liabilities | 3.04 | 3.03 | 2.66 | 3.2 | 3.32 | 1.32 | Upgrade
|
Long-Term Leases | 0.08 | 0.08 | 0.18 | 0.45 | 0 | 0.02 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.09 | - | Upgrade
|
Total Liabilities | 3.12 | 3.11 | 2.84 | 3.66 | 3.41 | 1.34 | Upgrade
|
Common Stock | 60.99 | 60.99 | 60.99 | 62.52 | 63.06 | 41.37 | Upgrade
|
Additional Paid-In Capital | 6.87 | 6.87 | 3.05 | 1.36 | 1.36 | - | Upgrade
|
Retained Earnings | -66.93 | -65.91 | -49.45 | -43.09 | -22.44 | -15.35 | Upgrade
|
Comprehensive Income & Other | 11.51 | 11.69 | 14.88 | 14.79 | 14.42 | 9.82 | Upgrade
|
Shareholders' Equity | 12.43 | 13.63 | 29.46 | 35.59 | 56.39 | 35.84 | Upgrade
|
Total Liabilities & Equity | 15.55 | 16.75 | 32.3 | 39.24 | 59.8 | 37.17 | Upgrade
|
Total Debt | 0.2 | 0.19 | 0.41 | 0.68 | 0.03 | 0.1 | Upgrade
|
Net Cash (Debt) | 0.28 | 0.63 | 4.71 | 9.09 | 17.12 | 27.91 | Upgrade
|
Net Cash Growth | -92.02% | -86.72% | -48.16% | -46.92% | -38.64% | -15.65% | Upgrade
|
Net Cash Per Share | 0.00 | 0.01 | 0.04 | 0.07 | 0.16 | 0.28 | Upgrade
|
Filing Date Shares Outstanding | 119.39 | 119.39 | 119.39 | 122.4 | 123.45 | 99.46 | Upgrade
|
Total Common Shares Outstanding | 119.39 | 119.39 | 119.39 | 122.4 | 123.45 | 99.72 | Upgrade
|
Working Capital | 1.41 | 2.33 | 7.93 | 13.45 | 20.97 | 29.9 | Upgrade
|
Book Value Per Share | 0.10 | 0.11 | 0.25 | 0.29 | 0.46 | 0.36 | Upgrade
|
Tangible Book Value | 12.32 | 13.45 | 28.97 | 34.78 | 42.07 | 34.37 | Upgrade
|
Tangible Book Value Per Share | 0.10 | 0.11 | 0.24 | 0.28 | 0.34 | 0.34 | Upgrade
|
Land | - | 3.7 | 4.58 | 4.42 | 4.18 | 2.22 | Upgrade
|
Machinery | - | 5.66 | 6.06 | 5.82 | 4.76 | 1.81 | Upgrade
|
Construction In Progress | - | 6.32 | 12.05 | 11.96 | 12.66 | 0.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.